ArticleHepatobiliary surgery and nutrition2018

The first-line treatment for unresectable hepatocellular carcinoma patients: lenvatinib versus sorafenib, or beyond?

Feihu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.